期刊文献+

氯沙坦联合双氢克尿噻治疗原发性高血压疗效观察 被引量:1

Efficacy of Iosartan combined with hydrochlorothiazide in treatment of essential hypertension
原文传递
导出
摘要 目的观察氯沙坦联合双氢克尿噻治疗原发性高血压的疗效及安全性。方法40例原发性高血压患者,每天服氯沙坦50mg、双氢克尿噻12.5mg,观察降压疗效和对实验室检验结果的影响,在治疗2、4、8周末记录血压、心率及不良反应情况。结果治疗8周后血压明显下降(P〈0.01),总有效率90%。治疗前后心率,肝、肾功能,血脂,血糖,血尿酸,电解质等均无明显变化(P〉0.05)。结论氯沙坦联合双氢克尿噻治疗原发性高血压具有疗效好、不良反应少的优点。 Objective To evaluate the effects and safety of losartan and hydrochlorothiazide combination in treating essential hypertension. Methods Forty patients received losartan 50 mg and hydrochlorothiazide 12.5 mg once a day. Blood pressure and laboratory indexes were measured to evaluate its effect and safety. At the end of 2,4, 8 weeks after treatment, blood pressure, heart rate(HR) and adverse reaction were recorded. Results Blood pressure decreased significantly after 8 weeks treatment (P 〈 0.01 ). The total effective rates were 90%. There was no change in heart rate, liver and renal function, blood potassium, sodium, chlorine, blood lipid, blood glucose and blood uric acid before and after treatment ( P 〉 0.05). Conclusions Losartan combined with hydroehlorothiazide is effective in the treatment of essential hypertension with less side effect.
出处 《中国实用医刊》 2009年第13期32-33,共2页 Chinese Journal of Practical Medicine
关键词 氯沙坦 氢氯噻嗪 原发性高血压 Losartan Hydrochlorothiazide Essential hypertension
  • 相关文献

同被引文献4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部